Insider filing · BBIO
BridgeBio Pharma, Inc.
BBIO · Healthcare · 71 filings in 24 months
ticker →
KKR & Co. Inc. sold $149.3M of BridgeBio Pharma (BBIO)
Executed Sep 13 2024, disclosed Sep 17 2024, 4 days later.
Value, as filed
$149.3M
5,800,000 sh × $25.75
Executed
Sep 13 2024
the trade date, as filed
Disclosed
Sep 17 2024
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KI
KKR & Co. Inc.
10% owner
profile →
KKR & Co. Inc. (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in BrightSpring Health Services, Inc. (BTSG). The largest single filing was $807.5M of BTSG (19,715,000 sh × $40.96, as filed), executed Mar 4.
The name
BBIOHealthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→